|
1
|
Lericque V, Chen Y, Defrance F, Kerr-Conte J, Vantyghem MC. Real-life experience with DPP4 inhibitors for graft dysfunction after human islet allotransplantation. Ann Endocrinol (Paris) 2024; 85:166-168. [PMID: 38336564 DOI: 10.1016/j.ando.2024.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 01/24/2024] [Accepted: 01/25/2024] [Indexed: 02/12/2024]
Affiliation(s)
- Valentin Lericque
- U1190 Translational Research for Diabetes, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France; European Genomic Institute for Diabetes, University of Lille, Lille, France
| | - Yuetong Chen
- U1190 Translational Research for Diabetes, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France; Department of Endocrinology, Diabetology, and Metabolism, Lille University Hospital, Lille, France
| | - Frédérique Defrance
- Department of Endocrinology, Diabetology, and Metabolism, Lille University Hospital, Lille, France
| | - Julie Kerr-Conte
- U1190 Translational Research for Diabetes, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France; European Genomic Institute for Diabetes, University of Lille, Lille, France
| | - Marie-Christine Vantyghem
- U1190 Translational Research for Diabetes, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France; European Genomic Institute for Diabetes, University of Lille, Lille, France; Department of Endocrinology, Diabetology, and Metabolism, Lille University Hospital, Lille, France.
| |
Collapse
|